NEW YORK (GenomeWeb News) – Pressure BioSciences saw revenues in its third quarter climb 7 percent year over year as revenues derived from its Pressure Cycling Technology grew 10 percent, the company said today.

The South Easton, Mass.-based firm said that total revenues reached $420,762 for the three months ended Sept. 30, compared to $391,616 a year ago. Revenues from PCT products, services, and other were $327,958, compared to $297,867 a year ago, while grant revenues narrowed to $92,804 from $93,749.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.